Who we help

Longevity & anti-ageing patients

For the health-conscious 45–65 traveller investing in exosome and cell-based revitalisation.

For Longevity & anti-ageing patients
A calm, private EU clinical setting.

Longevity and rejuvenation claims require product-specific evidence and measurable clinical endpoints. Biomarker movement, wellness recovery and aesthetic change are not interchangeable with proven healthspan benefit.

How to evaluate Bulgaria for your situation

  • Verify the identity, regulation and human evidence for every exosome or fibroblast preparation.
  • Treat spa and mineral-spring services as optional supportive care, not proof of a cell intervention.
  • EU location does not establish product authorisation, quality or efficacy.
  • Use current itemised inputs to plan travel and recovery separately.

Compare like with like

Country ranges may describe different products, doses, visits and inclusions. Request itemised current quotations, record each source and retrieval date, and verify the regulatory status of the exact proposal before comparing totals.

Safety & practicalities note

EUBulgaria is an EU member state, but that does not verify a specific provider, product or treatment.
Check current government travel advice, insurance, accessibility and emergency arrangements for your own dates.
Entry requirements vary by nationality and trip length. Check current official Bulgarian guidance before booking.
Request a current written quotation with inclusions, exclusions, cancellation and refund terms.

This note is general information for planning, not legal or medical advice. Confirm entry rules for your nationality before booking.

Your situation, specifically

These conditions are the most relevant for your situation:

An online guide cannot determine candidacy. Ask an independent qualified clinician to review the proposed product, evidence, risks and alternatives before you consent or pay.

Educational information. Outcomes vary by patient; consult a qualified physician.

Explore all sections · Data & downloads

Compare cell-therapy evidence, registered studies and published price observations.

StemCellAtlas is a source-first research and cost-planning guide. It separates registry and regulator evidence from heterogeneous commercial observations.

Request written information